Mutations in SLC12A5 in epilepsy of infancy with migrating focal seizures
Citations Over TimeTop 10% of 2015 papers
Abstract
The potassium-chloride co-transporter KCC2, encoded by SLC12A5, plays a fundamental role in fast synaptic inhibition by maintaining a hyperpolarizing gradient for chloride ions. KCC2 dysfunction has been implicated in human epilepsy, but to date, no monogenic KCC2-related epilepsy disorders have been described. Here we show recessive loss-of-function SLC12A5 mutations in patients with a severe infantile-onset pharmacoresistant epilepsy syndrome, epilepsy of infancy with migrating focal seizures (EIMFS). Decreased KCC2 surface expression, reduced protein glycosylation and impaired chloride extrusion contribute to loss of KCC2 activity, thereby impairing normal synaptic inhibition and promoting neuronal excitability in this early-onset epileptic encephalopathy.
Related Papers
- → People with epilepsy are diagnosed most often with unspecified epilepsy, followed by focal epilepsy, generalized convulsive epilepsy, and generalized nonconvulsive epilepsy—US MarketScan data, 2010–2015(2017)13 cited
- → Evaluation of physical educators' knowledge about epilepsy(2010)21 cited
- Update of the medical treatment of West syndrome.(2007)
- [Occurrence of epilepsy, its types and course during the first decade of life in progeny of mothers with epilepsy--prospective study].(2001)
- → West Syndrome: A Case Report(2023)